Advertisement
Advertisement
U.S. Markets close in 1 hr 34 mins
Advertisement
Advertisement
Advertisement
Advertisement

Braxia Scientific Corp. (BRAXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1070-0.0080 (-6.96%)
As of 03:59PM EST. Market open.
Advertisement

Braxia Scientific Corp.

1430 Hurontario Street
Mississauga, ON L5G 3H4
Canada

http://www.braxiascientific.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Roger S. McIntyreChairman & CEON/AN/AN/A
Mr. Stephen R. BrooksChief Financial OfficerN/AN/AN/A
Mr. Peter RizakosGen. CounselN/AN/AN/A
Dr. Joshua RosenblatChief Medical & Scientific OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario.

Corporate Governance

Braxia Scientific Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement